COVID-19 Vaccine and Therapeutics Pipeline Analysis

0

COVID-19-CoronaVirus-Pipeline-therapies-

DelveInsight’s Overview of the COVID-19 pipeline The report provides a comprehensive overview of the therapies under development that are in different stages of clinical and preclinical development, their launch and how the market is expected to transform in the COVID-19 area thereafter.

the COVID-19 pipeline analysis The report offers an in-depth analysis of the therapeutic landscape by stage of development, product type, route of administration, molecule type and MOA for emerging COVID-19 therapies. The Pipeline report describes business opportunities, threats, potential collaborations, strong competitors, and growth strategies.

Some of the highlights from the COVID-19 pipeline report:

  • COVID-19 continues to pose a serious public health concern around the world, however, more than 8 vaccines have been approved for emergency use in recent months with multiple therapies underway, while few trials of vaccines were discontinued after insufficient results. .
  • Currently, clinical management includes infection prevention and control measures. Sometimes supportive care such as supplemental oxygen and mechanical ventilation assistance is also needed in some severe cases.
  • Currently, the three main types of COVID-19 vaccines namely mRNA vaccine, protein subunit vaccines and vector vaccines are available in the market. Global pharmaceutical and biotechnology companies are actively exploring potential new vaccines, with many of the emerging vaccines at an advanced stage.
  • At present, more than 150+ key companies are involved in the development of therapies for COVID-19 including Novavax, Capricor Therapeutics, Imv Inc., AbbVie, Amgen, Synairgen, Maxwell Biosciences, Veru Inc., Galera Therapeutics, Sorrento Therapeutics, Xenothera, RSV Therapeutics, and many more.
  • Some Emerging COVID-19 therapies should enter the market include MXB-009, DPX COVID 19, CAP-1002, GC4419, Otezla, SNG001, PSC 04, ABBV-47D11, XC221, XAV-19, and many others.
  • Among emerging therapies ZyCoV-D, VLA2001, ARCoV, NVX-CoV2373, Corbevax, Vidprevtyn and Nanocovax are in the most advanced stage (Phase III) of vaccine development.

Sample request @ Overview and outlook of the COVID-19 pipeline

COVID-19 pipeline therapies

  • MXB-009
  • DPX COVID 19
  • CAP-1002
  • GC4419
  • Otezla
  • SNG001
  • CFP 04
  • IPC-006
  • Bucillamine
  • Losmapimod
  • ABBV-47D11

And much more

The list of emerging therapies is not exhaustive, the full list will be provided in the final report, visit to find out more @ COVID-19 Therapeutics and Drugs Pipeline

Key companies in the COVID-19 therapeutic landscape:

  • Capricor Therapeutics
  • Imv Inc.
  • Kinarus
  • Veru inc.
  • Novavax
  • AbbVie
  • Amgen
  • Synairgen research
  • Xenothera
  • Zydus Cadila
  • RSV therapy
  • Maxwell Biosciences
  • Therapeutic Galera
  • Sorrento Therapeutics
  • Corvus Pharmaceuticals
  • Therapeutic Fulcrum
  • Revive Therapeutics

And many more.

Therapeutic evaluation of the COVID-19 pipeline

By product type

  • Monotherapy
  • Combined therapy

By step

  • Discovery
  • Pre-clinic
  • Phase I
  • Phase II
  • Phase III
  • Pre-registration

By route of administration

  • Oral
  • Intravenous
  • Inhalation
  • Subcutaneous

By molecule type

  • Small Molecule
  • Genetical therapy
  • Stem cell therapy

Targets:

  • Interferon beta-1a
  • Mitogen-activated protein kinase P38
  • Cyclic nucleotide phosphodiesterase type 4
  • Superoxide dismutase
  • Viral envelope protein

By mechanism of action

  • Interferon beta 1a replacements
  • Mitogen-activated protein kinase inhibitors P38
  • Cell replacements
  • Cyclic nucleotide phosphodiesterase type 4 inhibitors
  • Virus internalization inhibitors
  • Immunostimulants
  • Antioxidants
  • Viral envelope protein inhibitors
  • Angiotensin type 2 receptor agonists

You have questions ? Contact us for more information @ COVID-19 Drug Pipeline Assessment

Scope of the report

  • Blanket: Global
  • Key market players: Novavax, Zydus Cadila, Capricor Therapeutics, Imv Inc., AbbVie, Amgen, Synairgen, Maxwell Biosciences, Kinarus, Galera Therapeutics, Sorrento Therapeutics, Xenothera, RSV Therapeutics and many more.
  • Key pipeline therapies: MXB-009, DPX COVID 19, CAP-1002, GC4419, Otezla, SNG001, PSC 04, ABBV-47D11, XC221, XAV-19 and many more.

Contents

1

Presentation of the report

2

COVID-19[female[feminine

3

COVID-19 Current Treatment Models

4

COVID-19 – Analytical Perspective from DelveInsight

5

Therapeutic evaluation

6

Advanced COVID-19 Products (Phase-III)

7

COVID-19 Mid Stage (Phase-II) Products

8

Early stage COVID-19 products (Phase-I)

9

COVID-19 preclinical products and products at the discovery stage

ten

Inactive products

11

Dormant products

12

Discontinued COVID-19 products

13

COVID-19 Product Profiles

14

Key COVID-19 companies

15

COVID-19 key products

16

Dormant and abandoned products

17

COVID-19 Unmet Needs

18

Future prospects of COVID-19

19

COVID-19 Analyst Review

20

Annex

21

Methodology of the report

Learn more about what’s covered in the COVID-19 pipeline assessment report

Key questions addressed in the COVID-19 report

  • What are the current options for COVID-19 treatment?
  • How many companies are developing therapies for the treatment of COVID-19?
  • What are the main therapies developed by these companies in the industry?
  • How many therapies are being developed by each company for the treatment of COVID-19?
  • How many emerging COVID-19 therapies are in early, intermediate and advanced stages of development for the treatment of COVID-19?
  • Of the total products in the pipeline, how many therapies are administered as monotherapy and in combination with other therapies?
  • What are the key collaborations (Industry-Industry, Industry-University), mergers and acquisitions and major licensing activities that will impact the COVID-19 market?

Webex Demo Request @ COVID-19 drug pipeline and discover our report

Latest reportsCompetitive Landscape of the Therapeutic Pipeline, Vaccines and Diagnostics of COVID 19 (Novel Coronavirus 19)DelveInsight’s report on “COVID 19 (Novel Coronavirus 19) Therapeutic Pipeline, Vaccines, and Diagnostics Competitive Landscape” covers detailed analysis of companies working for drug and vaccine development as well as diagnostic companies working on kit development test. The report also provides a solid foundation for advancing research and analysis on COVID 19 covering morbidity and mortality.

MRNA vaccines and therapeutic products marketDelveInsight’s “Global Messenger RNA (mRNA) based Vaccines and Therapeutics Market Insights, Epidemiology, and Market Forecast 2030” report provides an in-depth understanding of mRNA-based vaccines and therapeutics, along with its historical and predicted epidemiology and trends. market in North America, Europe, Asia and ROW (rest of the world).

Plasmacytoid Blast Dendritic Cell Neoplasm (BPDCN) MarketThe DelveInsight report “Blastic Plasmacyoid Dendritic Cell Neoplasm (BPDCN) Market Insights, Epidemiology, and Market Forecast 2030” provides an in-depth understanding of the disease, historical and predicted epidemiology as well as Blastic Plasmacytoid Dendritic Cell Neoplasm market trends (BPDCN) in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.

Anti-hypertension marketDelveInsight’s “Anti-hypertension Market Insights, Epidemiology, and Market Forecast 2030” report provides an in-depth understanding of the historical and predicted epidemiology as well as the Anti-hypertension market size and share analysis in the 7MMs (i.e. the United States, the EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan).

Acute Pyelonephritis MarketDelveInsight’s “Acute Pyelonephritis Market Insights, Epidemiology, and Market Forecast 2030” report provides an in-depth understanding of the historical and predicted epidemiology as well as Acute Pyelonephritis market size and share analysis within 7MM (i.e. USA, EU5 (Germany), Spain, Italy, France and UK) and Japan).

Corneal Endothelial Dystrophy MarketThe report from DelveInsight “Corneal Endothelial Dystrophy Market Insights, Epidemiology, and Market Forecast 2030” provides an in-depth understanding of the historical and predicted epidemiology as well as Corneal Endothelial Dystrophy Market size and share analysis in 7 MM (i.e. US, EU5 (Germany, Spain, Italy, France and UK) and Japan).

Type 2 Diabetes MarketDelveInsight’s “Type 2 Diabetes Market Insights, Epidemiology, and Market Forecast 2030” report provides an in-depth understanding of the historical and predicted epidemiology as well as Type 2 Diabetes market size and share analysis in 7MM (i.e. USA, EU5 (Germany, Spain, Italy, France and UK) and Japan).

Health Blogs by DelveInsight

About SearchInsightDelveInsight is a leading business consulting and market research firm focused exclusively on the life sciences. It supports pharmaceutical companies by providing them with complete end-to-end solutions to improve their performance. Get hassle-free access to all healthcare and pharmaceutical market research reports through our subscription platform PharmaDelve.

Connect with us at LinkedIn | Facebook | Twitter

Keywords: , , ,

See the campaign: https://www.delveinsight.com/Contact details: Shruti Thakur [email protected] +1(919)321-6187 Keywords:, PR-Wirein, Menafn, IPS, Reported hours, Extended distribution, ICN internal distribution, Research News Wire, Englishpicture

Contact details:

Shruti Thakur [email protected] +1(919)321-6187



Source link

Leave A Reply

Your email address will not be published.